Literature DB >> 29478744

Tricuspid annulus diameter does not predict the development of tricuspid regurgitation after mitral valve repair for mitral regurgitation due to degenerative diseases.

Tirone E David1, Carolyn M David2, Cedric Manlhiot2.   

Abstract

BACKGROUND: Heart valve surgery guidelines suggest that tricuspid valve annuloplasty may be beneficial in patients with a tricuspid annulus (TA) ≥40 mm even in the absence of functional tricuspid regurgitation (TR) at the time of surgery for left-sided valve lesions (class 2a). Given the broad spectrum of degenerative diseases that affect the atrioventricular valves, we hypothesize that this measurement might not be predictive of TR after mitral valve (MV) repair.
METHODS: The diameter of the TA was measured preoperatively in a cohort of 312 consecutive patients who had isolated MV repair for degenerative diseases. The mean TA diameter was 36 mm (95% confidence interval [CI], 35-37 mm). TA ≥40 mm was present in 80 patients. The median duration of echocardiographic follow-up was 6.7 years (interquartile range, 5.4-8.4 years), and was 100% complete. The main study endpoint was postoperative TR of moderate or greater degree.
RESULTS: Thirty patients had new or persistent TR at some point during follow-up. The probability of postoperative TR at 7 years was 6.6% (95% CI, 4.6%-9.4%) for all patients, 6.8% (95% CI, 4.6%-10.4%) for TA <40 mm, and 6.0% (95% CI, 2.9%-12.2%) for TA ≥40 mm. Preoperative TA diameter was not associated with the odds of postoperative TR in either the univariable or multivariable regression models. In these analyses, preoperative TR was the strongest predictor of postoperative TR.
CONCLUSIONS: TA ≥40 mm is not predictive of the development of postoperative TR after MV repair for degenerative diseases.
Copyright © 2018 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  tricuspid annulus; tricuspid insufficiency; tricuspid valve

Mesh:

Year:  2018        PMID: 29478744     DOI: 10.1016/j.jtcvs.2017.12.126

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  Tricuspid valve annuloplasty at the time of mitral valve surgery: is it justified in all cases?

Authors:  Tirone E David
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-12-06

2.  Impact of concomitant tricuspid annuloplasty on right ventricular remodeling in patients with rheumatic mitral valve disease.

Authors:  Yue Zhong; Wenjuan Bai; Hui Wang; Hong Qian; Li Rao
Journal:  Cardiovasc Ultrasound       Date:  2021-03-04       Impact factor: 2.062

3.  Outcome of consistent guideline-based tricuspid management in patients undergoing degenerative mitral regurgitation correction.

Authors:  Gilles D Dreyfus; Benjamin Essayagh; Giovanni Benfari; Filip Dulguerov; Shelley Rahman Haley; Carine Dommerc; Adelin Albert; Maurice Enriquez-Sarano
Journal:  JTCVS Open       Date:  2021-07-20

4.  Rationale and surgical strategy for concomitant tricuspid repair.

Authors:  Joanna Chikwe; Dominick Megna
Journal:  JTCVS Open       Date:  2020-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.